Author: therawinformant

  • 2 ASX shares I’m never selling

    Smiling office man leaning back in chair in front of laptop

    Finding great ASX shares can be difficult, but that’s only half the challenge. The other half is holding onto great companies through good times and bad, to allow the magic of compounding increase your net worth. 

    This has become harder recently as there are plenty of great technology and innovation companies that fly past like meteors. However, there are still many companies that will deliver consistent growth, and consistent dividends. The secret is to buy them at a great price and hold onto them as they grow. 

    Resource ASX shares

    The iron ore industry has been the great constant in my life. It started before I was born, grew with me, and will be raging long after I am gone. As a result, I started purchasing shares in Fortescue Metals Group Limited (ASX: FMG) at approximately $8 per share. Today, my average dollar cost is around $10 per share. This means I was able to secure a high dividend paying share at a low price. 

    The company has a good future. It is in the finishing stages of developing two high grade iron ore mines, and selling into a market where demand is very strong. In addition, the company operates on solid operating margins. However, Fortescue is also expanding its metals portfolio. It recently announced a joint venture to explore part of the Paterson’s province in Western Australia for gold. Along with a number of exploration activities in South America for gold and copper. 

    Fortescue is selling at a price to earnings ratio (P/E) of 7.73, which is just under half of BHP Group Ltd (ASX: BHP). At this price it has a trailing 12-month (TTM) dividend yield of 10.86%.

    Finding solid resource investments like this in the early stages can be difficult. Right now, I think that two companies with potential for solid growth are Base Resources Limited (ASX: BSE), and maybe Ecograf Ltd (ASX: EGR).

    Real estate

    After the coronavirus market rout in March, I started to buy shares in Centuria Office REIT (ASX: COF). The company is a real estate investment trust (REIT), thus there are laws governing transparency and how much it has to pay out in distributions. I like this REIT for a few reasons.

    First, it is the country’s largest pure play office REIT. This means it is not diversified and directs all of its resources into commercial buildings. This sector has been quite resilient to COVID-19 in general, but more so for Centuria Office REIT. That is because many of the company’s tenants are government departments. Second, it has a long weighted average lease expiry, currently 4.7 years. 

    Right now the company is paying a TTM dividend yield of 8.48% and has a P/E of 12.6. I have no intention of selling this as it is a high paying dividend ASX share which forms part of my passive revenue streams. 

    Other companies that are similar right now include DEXUS Property Group (ASX: DXS), and Abacus Property Group (ASX: ABP).

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Daryl Mather owns shares of Centuria Office REIT and Fortescue Metals Group Limited. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 ASX shares I’m never selling appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3hRP8A7

  • Why now could be a good time to buy CSL (ASX:CSL) and ResMed (ASX:RMD) shares

    healthcare shares

    Like the rest of the market, the healthcare sector has been out of form over the last few weeks.

    This has led to the S&P/ASX 200 Health Care index losing 8% of its value in just a touch over a month.

    Given the quality on offer at this side of the market, I believe this has created a buying opportunity for long-term focused investors.

    With that in mind, here are two quality ASX healthcare shares I would buy today:

    CSL Limited (ASX: CSL)

    The CSL share price has been uncharacteristically out of form over the last few months and is down over 17% from its 52-week high. This has been driven by concerns over difficult plasma collection conditions. These collections are part of the manufacturing process for its lucrative immunoglobulins therapies. The pandemic is putting pressure on collection volumes, leading to lower donations and higher costs. This is likely to weigh on the margins of this key product range.

    However, I’m confident that the company will overcome this and still deliver solid earnings growth in FY 2021. Especially given the expected increase in demand for influenza vaccines in the Northern Hemisphere winter. Looking further ahead, I believe its research and development pipeline holds a number of very lucrative therapies which could be key drivers of growth in the future. Overall, I feel the recent weakness in the CSL share price is a fantastic buying opportunity for investors.

    ResMed Inc. (ASX: RMD)

    Another high quality ASX healthcare share to buy is ResMed. This sleep treatment-focused medical device company’s shares are down 21% from their 52-week high. I believe this is a buying opportunity for investors looking for long term options in the sector.

    This is because, thanks to its world class products, intuitive software solutions, and rapidly growing ecosystem, I’m confident the company can grow its earnings at a solid rate throughout the 2020s and beyond. Especially considering its massive and growing addressable market. Management estimates that there are 936 million sleep apnoea sufferers globally, with the vast majority of these undiagnosed. Given the growing education of the condition, I expect more and more diagnoses to be made over the coming years. This should underpin strong demand for ResMed’s products and software solutions.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of CSL Ltd. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Why now could be a good time to buy CSL (ASX:CSL) and ResMed (ASX:RMD) shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/32O0rVR

  • CBA, Macquarie face new $167m dirty cash allegations

    Toppled chess piece on top of pile of coins

    Commonwealth Bank of Australia (ASX: CBA) and Macquarie Group Ltd (ASX: MQG) have been accused of letting $167 million of criminal money move around the globe.

    International Consortium of Investigative Journalism (ICIJ) on Monday revealed a massive leak of confidential reports that showed overseas banks warning Australian counterparts about suspicious transactions.

    Despite this, more than $174 million of allegedly dirty money came in and out of Australian financial institutions. Macquarie alone was responsible for $123 million.

    CBA allegedly had $44 million come in or out of it that raised alarm bells with foreign banks.

    AUSTRAC is the Australian authority that oversees suspicious financial transactions. A couple of years ago, it raised a series of cases against local banks, including CBA and Westpac Banking Corp (ASX: WBC), about not reporting transactions that could be money laundering.

    Commonwealth Bank ended up copping a $700 million penalty as a result.

    Macquarie has previously avoided trouble with AUSTRAC, indicating the dodgy transactions shown in the ICIJ leak are a new discovery.

    The Motley Fool has contacted Macquarie for comment.

    A CBA spokesperson told The Motley Fool that the bank can’t comment on specific customers or transactions.

    “We recognise that we play a critical role in protecting our customers and the community from the risks associated with money laundering and terrorism financing,” said the spokesperson.

    “We work closely with law enforcement bodies that are involved in regulating and enforcing laws relating to financial crime.”

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Tony Yoo owns shares of Macquarie Group Limited. The Motley Fool Australia owns shares of and has recommended Macquarie Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post CBA, Macquarie face new $167m dirty cash allegations appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3cjOdHs

  • Is the Costa Group (ASX:CGC) share price a cheap buy?

    Costa Group Shares

    Costa Group Holdings Ltd (ASX: CGC) has slipped under my radar this year. The Costa Group share price surged higher in 2018 before its market value tumbled in troubled times last year.

    However, 2020 has been a funny year so far. The coronavirus pandemic has smashed many ASX shares and the March bear market saw valuations fall off a cliff. That wasn’t the case for the Costa Group share price which has managed to steadily climb 33.5% higher this year.

    That includes a 2.8% surge in yesterday’s trade, which has me wondering if the Aussie food producer’s shares are a cheap buy today.

    What does Costa Group do?

    Costa Group is Australia’s largest horticultural company and a major Aussie food producer. The company specialises in fresh fruit and vegetables with major products including avocados, berries, citrus, mushrooms and table grapes.

    The Costa Group share price has been performing well this year as the company’s market capitalisation has swelled to $1.34 billion with a 1.3% dividend yield.

    Why the company’s shares are surging

    It’s worth digging into why the Costa Group share price has been climbing in 2020. The major catalyst has been the strong demand factors, and more recently, a strong FY20 result.

    Supermarket sales have surged in 2020 as panic buying and the shutdown of the hospitality sector increased demand for groceries. That has been good news for major food producers like Costa Group and Bega Cheese Ltd (ASX: BGA).

    Strong demand translated into strong FY20 earnings as Costa Group posted a 6.8% increase in revenue to $612.4 million.

    Net profit after tax and before self-generating and regenerating assets, leasing and material items (NPAT-SL) jumped 12% to $45.8 million.

    That was enough to send the group’s shares surging to a new 52-week high of $3.74 per share in late August.

    Is the Costa Group share price a cheap buy?

    I think the FY21 outlook is still strong for Costa Group. Demand remains strong and tough restrictions are likely to boost supermarket sales in the early part of the year.

    The Costa Group share price has retreated from its 52-week high to $3.5 per share and could be worth a look given the strong fundamentals.

    These 3 stocks could be the next big movers in 2020

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended COSTA GRP FPO. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Is the Costa Group (ASX:CGC) share price a cheap buy? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3iMzbMZ

  • Got $3,000? Buy these exciting ASX growth shares

    asx blue chip shares

    If you have $3,000 to invest in ASX growth shares, then I think the ones listed below would be top options after recent market weakness.

    Here’s why I would invest $1,000 across each of these growth shares:

    Kogan.com Ltd (ASX: KGN)

    The first ASX growth to consider investing $1,000 into is Kogan. I believe this ecommerce company’s shares could be market beaters over the 2020s thanks to the continued rise in online shopping and the growing popularity of its Kogan-branded products and Marketplace. In addition to this, Kogan’s expansion into potentially lucrative verticals such as energy and mobile should be supportive of its growth. As should its $120 million capital raising. The company plans to use these funds to make value accretive acquisitions in the near future.

    NEXTDC Ltd (ASX: NXT)

    Another top ASX growth share for investors to put $1,000 into is NEXTDC. It is a growing data centre operator which owns a collection of world class centres in key locations across Australia. In FY 2020 NEXTDC delivered a 23% increase in EBITDA to $104.6 million. This was driven by strong demand for its data centre services thanks to the accelerating shift to the cloud because of the pandemic. The good news is that the cloud computing boom still has a long way to run. I believe this means NEXTDC is perfectly positioned for growth over the 2020s. 

    PolyNovo Ltd (ASX: PNV)

    A final option for investors to consider buying is PolyNovo. It is a growing medical device company behind the NovoSorb Biodegradable Temporising Matrix (BTM) product. This is a wound dressing which is designed to treat full-thickness wounds and burns. Management estimates that it currently has a sizeable $1.5 billion addressable market. Though, it isn’t settling for this and is looking to expand its use into other markets. It has its eyes on the hernia and breast treatment markets, which would add a further $6 billion to its addressable market.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro owns shares of NEXTDC Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd and POLYNOVO FPO. The Motley Fool Australia has recommended Kogan.com ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Got $3,000? Buy these exciting ASX growth shares appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3kBcAmV

  • Most Frequently Asked Questions about Automated Forex Trading Software Systems

    If you are new to forex trading, you have probably come across information related to automated trading software systems. An automated forex trading system is a software programmed to execute forex trading deals based on market trends and fluctuations. As a good trader, having a game plan increases your chances of making profits in the Read More…

    The post Most Frequently Asked Questions about Automated Forex Trading Software Systems appeared first on Wall Street Survivor.

    source https://blog.wallstreetsurvivor.com/2020/09/21/most-frequently-asked-questions-about-automated-forex-trading-software-systems/

  • 2 dirt-cheap ASX shares I would buy today

    man jumping for joy carrying shopping bags

    I love buying dirt-cheap ASX shares. Buying a good quality company at a cheap price greatly boosts your chances of enjoying market-beating returns in the years to come.

    Most of the time, the market prices an ASX share at a reasonable price (that’s how markets work, after all). But sometimes, the market gets something wrong, and either gives us investors a chance to sell our shares at far above their true value, or else buy shares at far below their true value.

    The 2 ASX shares I’ll name below are candidates (in my view) for such a mispricing right now. Here’s why.

    2 dirt-cheap ASX shares

    Telstra Corporation Ltd (ASX: TLS)

    Telstra is our first dirt-cheap ASX share. It’s the largest telco company on the ASX and has been in the wars of late. Last month, Telstra delivered its results for the 2020 financial year. In this report, Telstra reaffirmed an annual dividend of 16 cents per share, but also implicitly warned that its earnings in FY21 will be unlikely to cover the dividend going forward. However, Telstra does have sufficient free cash flow to cover 16 cents per share, so I think investors are being a little pessimistic on Telstra today. But that also means that new investors can buy Telstra and receive a trailing and fully franked dividend yield of 5.65% on current prices. That’s not a bad deal in my view.

    Cochlear Limited (ASX: COH)

    Cochlear is our second dirt-cheap ASX share to consider today. This company makes hearing aids and other hearing assistive devices and treatments. Much like its fellow health care company CSL Limited (ASX: CSL) Cochlear shares have always commanded a healthy premium compared to other ASX shares. And this premium has been well-deserved. Cochlear is a world-class company that sets the industry standard when it comes to hearing aid products. But I like it today because I think the shares are trading at a rare discount. The Cochlear share price remains more than 24% below its 52-week high and still down around 7% year to date.

    Sure, Cochlear has run into some issues during the pandemic, including delays in people getting Cochlear products installed. But in the long term, I don’t see any fundamental change to customers needing the services Cochlear provides. As such, I think today’s prices are a dirt-cheap deal for a long-term investor. You’ll also get a fully franked dividend worth a trailing 1.74% yield while you wait as well.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of June 30th

    More reading

    Motley Fool contributor Sebastian Bowen owns share of Telstra Limited. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Cochlear Ltd. and CSL Ltd. The Motley Fool Australia owns shares of and has recommended Telstra Limited. The Motley Fool Australia has recommended Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post 2 dirt-cheap ASX shares I would buy today appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/35XRPhw

  • New $280 million ASX tech share listing Wednesday

    Initial Public Offering (IPO)

    A financial technology company is listing Wednesday on the ASX with a market capitalisation of $280.3 million.

    Plenti Group Limited (ASX: PLT), formerly known as RateSetter, is set to become the latest tech player to intrigue investors looking for early growth.

    The company takes money from various sources – including retail investors – and lends it out to customers as personal, car or renewable energy loans.

    Plenti will start trading on Wednesday with an initial price of $1.66 per share. The company originally sought to raise $50 million via the initial public offering (IPO), but revised that to $55 million due to demand.

    Chief executive Daniel Foggo told The Motley Fool he always had an IPO in mind when he co-founded the business back in 2014.

    “We’ve always seen this as a natural destiny,” he said.

    “We’ve always had consumers funding our loans… So it’s quite a natural evolution to give them an opportunity to invest in the company.”

    That evolution was indeed fulfilled, with 20,000 retail loan ‘funders’ also becoming shareholders during the initial public offering.

    “Often one of the first questions [retail lenders] have asked us over the years is ‘When can we actually invest in the equity of the company?’”

    What’s Plenti’s moat?

    Borrowing and lending has been around for as long as humans, so The Motley Fool asked Foggo what makes Plenti different.

    “The technology aspect of our business provides us with a real competitive advantage,” he said.

    “It’s one of the key reasons why our revenue [annual growth rate] over the last 2 years is 60%.”

    Plenti owns and maintains all the technology end-to-end, according to Foggo, unlike some other startups that utilise licensed components or platforms.

    “It provides operational leverage so at scale we have really attractive economics.

    “Around a quarter of our staff are working on growth projects and technology or product roles. That’s quite a different ratio to a lot of other businesses.”

    Plenti started off as a peer-to-peer lender, meaning loans were entirely funded by other retail customers. But as the company grew, institutions like banks and fixed income funds joined in.

    “I think we’re the only fintech in Australia to have a superannuation fund funding credit.”

    Plenti’s diversified loan funding sources give it “resilience”, Foggo said.

    “It’s certainly times like these when you can see some sources of capital dry up. In the [global] financial crisis, we saw wholesale funding markets dry up.”

    Foggo does have the runs on the board running private companies. In 2016 and 2017, he won fintech industry awards for his leadership at what was then known as RateSetter. 

    He co-founded buy now, pay later provider PartPay, which was sold to Zip Co Ltd (ASX: Z1P) last year.

    Consumer borrowing during COVID-19

    Foggo told The Motley Fool that demand for personal loans certainly dipped when the COVID-19 pandemic arrived.

    But car and renewable energy loans have “performed exceptionally well”.

    “In our renewables business, we had a number of record lending months during the COVID period,” he said.

    “A lot of people were at home and they were investing in home improvements… and investing in solar panels.”

    Car loans initially dipped in April when all of Australia was in lockdown, but picked up afterwards as people sought to avoid public transport.

    “We really invested 3 or 4 years making sure we’re in the right position to grow in the automotive market. One of our shareholders, for example, is Carsales.Com Ltd (ASX: CAR).”

    Plenti earned $41.5 million in revenue for the year ending March, which was up 43.8% from the prior year. It forecasts $48.6 million for the 12 months to September. 

    The company made a $16.5 million net loss for the year ending March.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Tony Yoo has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of ZIPCOLTD FPO. The Motley Fool Australia has recommended carsales.com Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post New $280 million ASX tech share listing Wednesday appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/3mIyUNh

  • Can the Harvey Norman (ASX:HVN) share price maintain its momentum?

    wooden blocks spelling deal with one block saying yes and no representing wesfarmers share price

    The Harvey Norman Holdings Limited (ASX: HVN) share price jumped 2.1% on Monday after a strong sales update. The good times are rolling for the Aussie retailer right now but will they continue in 2021?

    Why the Harvey Norman share price jumped higher

    A strong trading update was the main catalyst for the solid capital gains in yesterday’s trade.

    Harvey Norman reported sales from 1 July 2020 to 17 September up 30.3% from the previous year. That’s an incredibly positive start to the new financial year buoyed by strong government stimulus and online sales channels.

    The Harvey Norman share price surged higher as unaudited preliminary accounts showed a 185.8% increase in profit before tax to $178.1 million.

    Can the momentum continue in 2021?

    Clearly, this strong sales growth won’t continue forever. That doesn’t mean that the Harvey Norman share price can’t climb higher on the back of short to medium-term growth outperformance.

    Retailers have surprised many commentators in the market this year. The coronavirus pandemic has weighed on economic growth and sparked a recession.

    That would normally see discretionary spending on retail, such as products sold by Harvey Norman, subside as consumers look to save more cash.

    2020 is no normal year and we’ve seen an uptick in retail spending. There could be a number of factors driving the move including the early access to superannuation scheme and strong government stimulus like JobKeeper.

    Whatever the cause, the Harvey Norman share price is riding the spending wave higher. Impressively, the ASX retail share could still be a cheap buy.

    The group’s shares are currently yielding 4.1% despite trading just below a 52-week high. That’s good news for investors looking for a reliable dividend share in the S&P/ASX 200 Index (ASX: XJO).

    On top of that, the Harvey Norman share price is trading at a price to earnings (P/E) ratio of 11.3x. That could mean its a good value buy compared to other ASX retail shares like Super Retail Group Ltd (ASX: SUL).

    Super Retail shares trade at a P/E of 19.2x with JB Hi-Fi Limited (ASX: JBH) shares at 18.0x.

    Foolish takeaway

    The Harvey Norman share price has rocketed 9.1% higher in 2020 but could have further to run given its current valuation.

    Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    Motley Fool contributor Ken Hall has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended Super Retail Group Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Can the Harvey Norman (ASX:HVN) share price maintain its momentum? appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/35We9rN

  • Jumbo (ASX:JIN) share price on watch after Tabcorp (ASX:TAH) sells its stake

    Lottery Balls

    The Jumbo Interactive Ltd (ASX: JIN) share price could come under pressure on Tuesday following the release of an after-hours announcement by Tabcorp Holdings Limited (ASX: TAH) on Monday.

    What was announced?

    After the market close on Monday, Tabcorp revealed that it will be selling its stake in Jumbo.

    According to the release, the gambling company has entered into an agreement to sell its 11.6% interest through a block trade with UBS.

    Tabcorp has agreed to sell 7,234,178 shares in Jumbo at a price of $13.52 per share. This represents a 6.1% discount to its last close price and will generate gross proceeds of approximately $98 million. The sale is expected to settle on 24 September 2020.

    After which, Tabcorp intends to use the proceeds to pay down its existing drawn bank debt facilities.

    Why is Tabcorp selling Jumbo shares?

    The company’s Managing Director and CEO, David Attenborough, revealed that it was selling its stake due to its new long-term agreement with Jumbo. This meant that the strategic investment was no longer necessary.

    Mr Attenborough explained: “Following the recent extension of our long-standing commercial distribution relationship with Jumbo for a ten year term to August 2030, there is no longer a strategic rationale for Tabcorp’s shareholding in Jumbo.”

    ‘As a result, we have decided to monetise this investment, with the resulting capital to be used to further strengthen the balance sheet and support the move towards our recently revised target gearing range,” he added.

    Tabcorp will record a profit after tax on the sale of approximately $69 million. This is expected to be reported as a significant item in its first half results.

    Should Jumbo shareholders be concerned?

    Given that the two companies now have a ten-year agreement in place, I wouldn’t be overly concerned by this news.

    While Tabcorp is responsible for the vast majority of Jumbo’s revenues at present, in ten years it should be a very different story.

    This is due to management’s bold international expansion plans for its Powered by Jumbo software as a service (SaaS) business. It notes that the global lottery market is worth US$303 billion a year, but just 7% of this market is online at the moment.

    These stocks could rocket in a Post-COVID world (FREE STOCK REPORT)

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

    *Returns as of 6/8/2020

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. recommends Jumbo Interactive Limited. The Motley Fool Australia owns shares of and has recommended Jumbo Interactive Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

    The post Jumbo (ASX:JIN) share price on watch after Tabcorp (ASX:TAH) sells its stake appeared first on Motley Fool Australia.

    from Motley Fool Australia https://ift.tt/32N2j14